What does FIGP mean in HUMAN GENOME

Fasting Insulin-Glucose Product (FIGP) is an important marker that reflects the overall metabolic state of an individual. It is used to evaluate a person's risk for type 2 diabetes and other metabolic diseases.

FIGP is measured by evaluating insulin and glucose levels in the bloodstream after a period of at least 8 hours without food intake.

Those with a family history of diabetes or any other diagnosed metabolic condition should consider getting their FIGP tested. It can also be beneficial to those who are overweight or obese, have high blood pressure, and/or cholesterol, or are taking certain medications that may affect metabolism.

A result that falls outside the normal range may indicate that you are at an increased risk for developing type 2 diabetes or another metabolic disease. If this happens, your doctor will likely recommend further testing or lifestyle changes to reduce your risk.

While measuring fasting insulin-glucose product can provide important information about a person's risk for type 2 diabetes, some people prefer alternative ways to assess their risk such as participating in preventive care programs geared toward reducing obesity and incorporating more physical activity into their lifestyle. Additionally, research has shown that intermittent fasting can also help improve glycemic control and reduce overall weight gain contributing to a healthier metabolic profile.